US2024018158A1PendingUtilityA1
Brm targeting compounds and associated methods of use
Est. expiryJun 9, 2040(~13.9 yrs left)· nominal 20-yr term from priority
C07D 487/14C07D 519/00A61P 35/00A61P 35/02
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides bifunctional compounds comprising a target protein binding moiety and a E3 ubiquitin ligase binding moiety, and associated methods of use.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A compound of Formula (I):
PTM-ULM (I)
or a pharmaceutically acceptable salt or solvate thereof, wherein
PTM is a moiety of Formula IA:
wherein
R 1 is a covalent bond, or chemical moiety that links PTM and ULM;
* is a point of attachment to ULM;
n=0-3;
W is optionally substituted —CH 2 —, —C(O)—, —S(O)—, or —S(O) 2 —; wherein when n=2 or 3, only one W may be —C(O)—, —S(O)—, or —S(O) 2 —;
R c1 and R d1 are independently H, D, Halo, C 1-3 alkyl, C 1-3 haloalkyl, or C 1-4 alkoxyl;
R e3 is H, —C(O)R f , or —P(O)(OR g ) 2 ; wherein R f and R g are independently H, C 1-4 alkyl, C 1-4 substituted alkyl, C 3-8 cyclcoalkyl, C 3-8 substituted cyclcoalkyl, C 3-8 heterocyclcoalkyl, or C 3-8 substituted heterocyclcoalkyl;
Z and Y are each independently N; CR h wherein R h ═H or absent; or, if R 1 is attached to Z, then Z is C and Y is N or CR h wherein R h is H; or if R 1 is attached to Y, then Y is C and Z is N or CR h wherein R h is H;
B is an optionally substituted 5-7 membered cycloalkyl ring, an optionally substituted 5-7 membered heteroaryl ring, or an optionally substituted 5-7 membered heterocyclic ring, wherein ring B is fused to ring C through Y and Z; and ULM is a small molecule E3 Ubiquitin Ligase binding moiety that binds a Von Hippel-Lindau E3 Ubiquitin Ligase.
2 . The compound according to claim 1 , wherein R 1 is a covalent bond.
3 . The compound according to claim 1 , wherein R 1 is a chemical moiety represented by the formula:
-(A) q -, wherein:
q is an integer from 1 to 14;
each A is independently selected from the group consisting of CR 1a R 1b O, S, SO, SO 2 , NR 1c , SO 2 NR 1c , SONR 1c , SO(═NR 1c ), SO(═NR 1c )NR 1d , CONR 1c , NR 1c , CONR 1d NR 1c C(O)O, NR 1c SO 2 NR 1d , CO, CR 1a ═CR 1b , C≡C, SiR 1a R 1b , P(O)R 1a , P(O)OR 1a (CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 S(CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 NR(CR 1a R 1b ) 1-4 NR 1c C(═NCN)NR 1d NR 1c C(═NCN), NR 1c C(═CNO 2 )NR 1d , 3-11 membered cycloalkyl, optionally substituted with 0-6 R 1a and/or R 1b groups, 3-11 membered heteocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups, aryl optionally substituted with 0-6 R 1a and/or R 1b groups, or heteroaryl optionally substituted with 0-6 R 1a and/or R 1b groups,
wherein R 1a , R 1b , R 1c , R 1d , and R 1e are each independently, —H, D, -halo, —C 1 -C 8 alkyl, —O—C 1 -C 8 alkyl, —C 1 -C 6 haloalkyl, —S—C 1 -C 8 alkyl, —NHC 1 -C 8 alkyl, —N(C 1 -C 8 alkyl) 2 , 3-11 membered cycloalkyl, aryl, heteroaryl, 3-11 membered heterocyclyl, —O—(3-11 membered cycloalkyl), —S—(3-11 membered cycloalkyl), NH—(3-11 membered cycloalkyl), N(3-11 membered cycloalkyl) 2 , N-(3-11 membered cycloalkyl)(C 1 -C 8 alkyl), —OH, —NH 2 , —SH, —SO 2 C 1 -C 8 alkyl, SO(NH)C 1 -C 8 alkyl, P(O)(OC 1 -C 8 alkyl)(C 1 -C 8 alkyl), —P(O)(OC 1 -C 8 alkyl) 2 , —C≡C—C 1 -C 8 alkyl, —C≡CH, —CH═CH(C 1 -C 8 alkyl), —C(C 1 -C 8 alkyl)═CH(C 1 -C 8 alkyl), —C(C 1 -C 8 alkyl)═C(C 1 -C 8 alkyl) 2 , —Si(OH) 3 , —Si(C 1 -C 8 alkyl) 3 , —Si(OH)(C 1 -C 8 alkyl) 2 , —C(O)C 1 -C 8 alkyl, —CO 2 H, —CN, —CF 3 , —CHF 2 , —CH 2 F, —NO 2 , —SF 5 , —SO 2 NHC 1 -C 8 alkyl, —SO 2 N(C 1 -C 8 alkyl) 2 , —SO(NH)NHC 1 -C 8 alkyl, —SO(NH)N(C 1 -C 8 alkyl) 2 , —SONHC 1 -C 8 alkyl, —SON(C 1 -C 8 alkyl) 2 , —CONHC 1 -C 8 alkyl, —CON(C 1 -C 8 alkyl) 2 , —N(C 1 -C 8 alkyl)CONH(C 1 -C 8 alkyl), —N(C 1 -C 8 alkyl)CON(C 1 -C 8 alkyl) 2 , —NHCONH(C 1 -C 8 alkyl), —NHCON(C 1 -C 8 alkyl) 2 , —NHCONH 2 , —N(C 1 -C 8 alkyl)SO 2 NH(C 1 -C 8 alkyl), —N(C 1 -C 8 alkyl)SO 2 N(C 1 -C 8 alkyl) 2 , —NHSO 2 NH(C 1 -C 8 alkyl), —NHSO 2 N(C 1 -C 8 alkyl) 2 , or —NHSO 2 NH 2 ; and where R 1a or R 1b , each independently may be optionally linked to other groups to form cycloalkyl and/or heterocyclyl moiety, optionally substituted with 0-4 R 1e groups.
4 . The compound according to claim 3 , wherein q=4 and R 1 is a chemical moiety represented by the formula:-A 1 -A 2 -A 3 -A 4 -, wherein each of A 1-4 is independently selected from the group consisting of O, S, SO, SO 2 , NR 1c SO 2 NR 1c SONR 1c , SO(═NR 1c ), SO(═NR 1c )NR 1d , CONR 1c , NR 1c , CONR 1d , NR 1c C(O)O, NR 1c SO 2 NR 1d , CO, CR 1a ═CR 1b , C≡C, SiR 1a R 1b , P(O)R 1a , P(O)OR 1a , (CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 S(CR 1a R 1b ) 1-4 , —(CR 1a R 1b ) 1-4 NR(CR 1a R 1b ) 1-4 , optionally substituted 3-11 membered cycloalkyl, 3-11 membered heterocyclyl, aryl, and heteroaryl;
wherein R 1a and R 1b are each independently selected from the group consisting of —H, D, -halo, —C 1 -C 8 alkyl, —O—C 1 -C 8 alkyl, —C 1 -C 6 haloalkyl —S—C 1 -C 8 alkyl —NHC 1 -C 8 alkyl —N(C 1 -C 8 alkyl) 2 , 3-11 membered cycloalkyl, aryl, heteroaryl, 3-11 membered heterocyclyl, —O—(3-11 membered cycloalkyl), —S—(3-11 membered cycloalkyl), NH—(3-11 membered cycloalkyl), N(3-11 membered cycloalkyl) 2 , N-(3-11 membered cycloalkyl)(C 1 -C 8 alkyl), —OH, —NH 2 , —SH, —SO 2 C 1 -C 8 alkyl, SO(NH)C 1 -C 8 alkyl, P(O)(OC 1 -C 8 alkyl)(C 1 -C 8 alkyl), —P(O)(OC 1 -C 8 alkyl) 2 , —C≡C—C 1 -C 8 alkyl, —C≡CH, —CH═CH(C 1 -C 8 alkyl), —C(C 1 -C 8 alkyl)═CH(C 1 -C 8 alkyl), —C(C 1 -C 8 alkyl)═C(C 1 -C 8 alkyl) 2 , —Si(OH) 3 , —Si(C 1 -C 8 alkyl) 3 , —Si(OH)(C 1 -C 8 alkyl) 2 , —C(O)C 1 -C 8 alkyl, —CO 2 H, —CN, —NO 2 , —SF 5 , —SO 2 NHC 1 -C 8 alkyl, —SO 2 N(C 1 -C 8 alkyl) 2 , —SO(NH)NHC 1 -C 8 alkyl, —SO(NH)N(C 1 -C 8 alkyl) 2 , —SONHC 1 -C 8 alkyl, —SON(C 1 -C 8 alkyl) 2 , —CONHC 1 -C 8 alkyl, —CON(C 1 -C 8 alkyl) 2 , —N(C 1 -C 8 alkyl)CONH(C 1 -C 8 alkyl), —N(C 1 -C 8 alkyl)CON(C 1 -C 8 alkyl) 2 , —NHCONH(C 1 -C 8 alkyl), —NHCON(C 1 -C 8 alkyl) 2 , —NHCONH 2 , —N(C 1 -C 8 alkyl)SO 2 NH(C 1 -C 8 alkyl), —N(C 1 -C 8 alkyl)SO 2 N(C 1 -C 8 alkyl) 2 , —NHSO 2 NH(C 1 -C 8 alkyl), —NHSO 2 N(C 1 -C 8 alkyl) 2 , or —NHSO 2 NH 2 ; and
R 1c and R 1d are each independently selected from the group consisting of H, D, optionally substituted C 1-4 alkyl, C 3-8 cyclcoalkyl, C 3-8 heterocyclcoalkyl, aryl, or heteroaryl.
5 . The compound according to claim 1 , wherein R 1 is a 3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups, 3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups, —(CR 1a R 1b ) 1-5 , —(CR 1a ═CR 1b )—, —(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 —(CR 1a ═CR 1b )—(CR 1a R 1b ) 1-5 -A-(CR 1a R 1b ) 1-5 —(CR 1a ═CR 1b )—(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 —(C≡C)—(CR 1a R 1b ) 1-5 —, —(CR 1a R 1b ) 1-5 -A-(C≡C)—(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(C≡C)—(CR 1a R 1b ) 1-5 -A-(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(C≡C)—(CR 1a R 1b ) 1-5 , —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-, —(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-, -(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 —, -(3-11 membered heterocyclyl optionally substituted with 0-6 Rea and/or R 1b groups)- (CR 1a R 1b ) 1-5 —, —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-A-, —(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-A-, —(CR 1a R 1b ) 1-5 , -(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CR 1a R 1b ) 1-5 —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-A- wherein A is O, S, or NR 1c —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CR 1a R 1b ) 1-5 , —(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 —(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein each A is independently O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CR 1a R 1b ) 1-5 -A- wherein each A is independently O, S, or NR 1c , —(CR 1a R 1 ) 1-5 -A-(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(CR 1a R 1b ) 1-5 -A-(CR 1a R 1b ) 1-5 -A-(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(CO) wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(CR 1a ═CR 1b )—(CR 1a R 1b ) 1-5 -A-(CO)— wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 —(C≡C)—(CR 1a R 1b ) 1-5 -A-(CO)— wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 —(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CR 1a R 1b ) 1-5 -A-(CO)— wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(CO)-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 —(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A-(CO)— wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(CO)-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-A-(CO)— wherein each A is independently O, S, or NR 1c , -(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups) 1-5 -(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 —(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CR 1a R 1b ) 1-5 -A-(CO)— wherein A is O, S, or NR 1c , —(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A-(CO)—wherein A is O, S, or NR 1c , -(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 —, or -(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 —, -(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CO)—(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c ; -(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CO)-A-(CR 1a R 1b ) 1-5 — wherein A is O, S, or NR 1c ; -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein each A is independently O, S, or NR 1c ; -(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CR 1a R 1b ) 1-5 -A-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c ; -(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c ; -(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)-A-(CR 1a R 1b ) 1-5 -A- wherein each A is independently O, S, or NR 1c ; -(heteroaryl optionally substituted with 0-4 R 1a and/or R 1b groups)-A-(CR 1a R 1b ) 1-5 — wherein A is O, S, or NR 1c ; -(3-11 membered heterocyclyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c ; -(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CO)—(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c ; -(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)-(CO)-A-(CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1c ; —(CO)-(3-11 membered cycloalkyl optionally substituted with 0-6 R 1a and/or R 1b groups)- (CR 1a R 1b ) 1-5 -A- wherein A is O, S, or NR 1 c.
6 . The compound according to claim 1 , wherein the compound of Formula IA is a compound of Formula IA-1:
7 . The compound according to claim 1 , wherein the compound of Formula IA is a compound of Formula IA-2:
8 . The compound according to claim 1 , wherein the compound of Formula IA is a compound of Formula IA-3:
wherein m=1 to 3;
X is optionally substituted —CH 2 —, or NH; or, if R 1 is attached to X, then X is —CH— or N; and Q is optionally substituted —CH 2 —, optionally substituted —(CH 2 ) 2 —, —C(O)—, optionally substituted —CH 2 C(O)—, —S(O)—, —S(O) 2 —, optionally substituted —CH 2 S(O) 2 —, or optionally substituted —CH 2 S(O)—.
9 . The compound according to claim 1 , wherein the compound of Formula IA is a compound of Formula IA-4:
wherein m=1 to 3; each R k is independently H, D, F, C 1-3 alkyl, C 1-3 haloalkyl, C 1-4 alkoxyl, substituted C 1-3 alkyl, substituted C 1-3 haloalkyl, or substituted C 1-4 alkoxyl; and s=0-7.
10 . The compound according to claim 9 , wherein the compound of Formula IA-4 is a compound of Formula IA-5:
11 . The compound according to claim 8 , wherein m=2.
12 . The compound according to claim 8 , wherein at least one W is optionally substituted —CH 2 —; and wherein when n=2 or 3, only one W may be —C(O)—, —S(O)—, or —S(O) 2 —.
13 . The compound according to claim 10 , wherein W is —CH 2 —.
14 . The compound according to claim 10 , wherein W is —CH(CH 3 )—.
15 . The compound according to claim 8 , wherein at least one W is —C(O)—.
16 . The compound according to claim 11 , wherein the compound of Formula IA-5 is a compound of Formula IA-6:
17 . The compound according to claim 1 , wherein R e3 is H.
18 . The compound according to claim 1 , wherein R d1 is H.
19 . The compound according to claim 9 , wherein s=0.
20 . The compound according to claim 1 , wherein R c1 is H.
21 . The compound according to claim 1 , wherein ULM is a moiety having the Formula ULM-I
wherein
the dashed line ( ) indicates the position of attachment of ULM-I to R 1 ;
V is H or F;
R 3 is optionally substituted phenyl, optionally substituted napthyl, or an optionally substituted 5-10 membered heteroaryl;
one of R 4 or R 5 is H, D, haloalkyl, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, —COR d , CONR e1 R e2 ;
the other of R 4 or R 5 is H or D;
or R 4 and R 5 , together with the carbon atom to which they are both attached, form an optionally substituted 3-5 membered cycloalkyl or heterocyclyl;
W 3 is an optionally substituted aryl, optionally substituted heteroaryl, or
R 6 and R 7 are independently H, D, optionally substituted alkyl, optionally substituted cycloalkyl, or optionally substituted haloalkyl,
or R 6 , R 7 , and the carbon atom to which they are attached form an optionally substituted cycloalkyl or optionally substituted heterocyclyl;
R 8 is an optionally substituted heterocyclyl, optionally substituted heteroaryl, optionally substituted aryl, CONR a R b NR a R b
R a is selected from H or optionally substituted alkyl;
R b is selected from H, —C(O)—* wherein * is a point of attachment to R 1 , optionally substituted alkyl, optionally substituted alkylcarbonyl, optionally substituted (cycloalkyl)alkylcarbonyl, optionally substituted aralkylcarbonyl, optionally substituted arylcarbonyl, optionally substituted (cycloalkyl)carbonyl, optionally substituted (heterocyclyl) carbonyl, or optionally substituted aralkyl;
each R c is independently H, halo, optionally substituted alkoxy, cyano, optionally substituted alkyl, haloalkyl, or haloalkoxy;
each R d is independently selected from H, optionally substituted alkyl or NR e1 R e2 ;
each R e1 and R e2 is independently H, D, optionally substituted alkyl,
or R e1 and R e2 together with the nitrogen atom to which they are attached form a 4-7 membered heterocyclyl; and
p is 0, 1, 2, 3, or 4.
22 .- 35 . (canceled)
36 . The compound according to claim 21 , wherein R 3 is optionally substituted phenyl having the formula:
wherein
R 9 is H, D, halo, —CN, —OH, —NO 2 , —NR e1 R e2 , —OR e1 , NR e1 COR e2 , —SO 2 NR e1 R e2 , —NR e1 SO 2 R e2 optionally substituted alkyl, optionally substituted alkoxyl, optionally substituted haloalkyl, optionally substituted haloalkoxy; optionally substituted aryl; optionally substituted heteroaryl; optionally substituted cycloalkyl; or optionally substituted heterocyclyl;
R 10 is H, D, halo, CN, optionally substituted alkyl, optionally substituted haloalkyl, hydroxy, —NH(optionally substituted alkyl), —N(optionally substituted alkyl) 2 , optionally substituted alkoxy, or optionally substituted haloalkoxy; and
z is 0, 1, 2, 3, or 4.
37 . The compound according to claim 36 , wherein R 9 is —CN, or
each optionally substituted.
38 . The compound according to claim 37 , wherein R 9 is
39 . The compound according to claim 36 , wherein R 10 is H, D, hydroxy, halogen, —NH(C 1 -C 4 alkyl), or C 1 -C 6 alkoxy, and z is 0, 1, 2, 3, or 4.
40 . The compound according to claim 21 , wherein
w 3 is
R 6 is H;
R 7 is H, or optionally substituted alkyl;
R 8 is
R a is H or optionally substituted alkyl;
R b is H, —C(O)—* wherein * is a point of attachment to R 1 , optionally substituted alkyl,
optionally substituted alkylcarbonyl, or optionally substituted (cycloalkyl)carbonyl.
41 . The compound according to claim 21 , wherein
R 7 is H, C 1 -C 6 alkyl, C 1 -C 6 alk-OH, C 1 -C 6 alk-NH 2 , —C 1 -C 6 alk-CONH—*, or —C 1 -C 6 alk-NHCO—*; R 8 is —NH—*, or —NHCOR 11 ;
* is a point of attachment of the ULM to R 1 ; and
R 11 is
42 . The compound according to claim 21 , wherein
W3 is R 8
R 6 is H;
R 7 is H, or optionally substituted alkyl;
R 8 is
R c is H or optionally substituted alkyl; and p=1.
43 . The compound according to claim 21 , wherein ULM-I is a compound of formula:
* is a point of attachment of the ULM to R 1 .
44 . The compound of claim 43 , wherein
R 9 is —CN or optionally substituted
and R 10 is H, D, hydroxy, halogen, —NH(C 1 -C 6 alkyl), or —OC 1 -C 6 alkyl.
45 . The compound of claim 44 , wherein
R 9 is
and R 10 is H, —F, or —OCH 3 .
46 .- 93 . (canceled)Join the waitlist — get patent alerts
Track US2024018158A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.